Skip to main content
. 2022 Aug 14;22:316. doi: 10.1186/s12893-022-01747-0

Table 1.

Hemostatic success of Hemopatch® and Surgicel® Original in VIBe SCALE grade 1 and grade 2 bleeding during the 10-min observation period post-application

Time (min) Overall (VIBe SCALE grade 1/2) VIBe SCALE grade 1 VIBe SCALE grade 2
Hemopatch® (N = 198) Surgicel® Original (N = 199) Hemopatch® (N = 99) Surgicel® Original (N = 100) Hemopatch® (N = 99) Surgicel® Original (N = 99)
n (%) n (%) n (%) n (%) n (%) n (%)
2 142 (71.7) 101 (50.8) 94 (94.9) 95 (95.0) 48 (48.5) 6 (6.1)
3 146 (73.7) 107 (53.8) 94 (94.9) 95 (95.0) 52 (52.5) 12 (12.1)
5 153 (77.3) 122 (61.3) 94 (94.9) 95 (95.0) 59 (59.6) 27 (27.3)
7 159 (80.3) 131 (65.8) 94 (94.9) 95 (95.0) 65 (65.7) 36 (36.4)
10 166 (83.8) 146 (73.4) 95 (96.0) 98 (98.0) 71 (71.7) 48 (48.5)